The strong accumulation of potential immunosupressive ARG+/IDO+/IL10+/TGF-β+M-/ PMN-MDSCs may be tumor-progression independent and may pose a significant impediment to the efficacy of anti-tumor responses elicited by (immuno)therapy. Here, IDO1 is linked to neoplasm.